Genprex
GNPX
14 hedge funds and large institutions have $93.5K invested in Genprex in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
62% less capital invested
Capital invested by funds: $247K → $93.5K (-$153K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$32.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$18.3K |
| 3 |
HF
HRT Financial
New York
|
+$14.4K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$11.7K |
| 5 |
HIP
HUB Investment Partners
Austin,
Texas
|
+$6.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$27.8K |
| 2 |
Goldman Sachs
New York
|
-$22.5K |
| 3 |
Morgan Stanley
New York
|
-$4.44K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.78K |
GNPX Hedge Fund Activity: Q1 2025 in Review
14 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2025, worth a combined $93.5K — down 62% from $247K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GNPX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $32.8K. The largest seller was Virtu Financial, cutting an estimated $27.8K.
- 14 institutional investors held Genprex (GNPX) as of Q1 2025, up from 13 in Q4 2024.
- Funds reported $93.5K of Genprex stock for Q1 2025, down 62% quarter-over-quarter.
- 3 funds opened new Genprex positions in Q1 2025 and 2 closed out, a net change of +1 holder.
- The largest Genprex buyer in Q1 2025 was HighTower Advisors, an estimated $32.8K added.
- The largest Genprex seller in Q1 2025 was Virtu Financial, an estimated $27.8K sold.
Based on aggregated 13F filings for Q1 2025.